Plasma cell-rich acute renal allograft rejection

Transplantation

Volumn 68, Issue 6, 1999, Pages 791-797

  Charney, Douglas A ^a   Nadasdy, Tibor ^a   Lo, Andy Wing Hong ^a   Racusen, Lorraine C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ACUTE KIDNEY TUBULE NECROSIS; ARTICLE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DISEASE; LYMPHOPROLIFERATIVE DISEASE; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ACUTE DISEASE; ADOLESCENT; ADULT; CADAVER; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA CELLS; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033610245     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909270-00011     Document Type: Article

References (21)

1. Racusen LC, Solez K, Olsen S. Pathology of kidney transplantation. In: Racusen LC, Solez K, Burdick JF, eds. Kidney Transplant Rejection - Diagnosis and Treatment, 3rd Ed. New York, Marcel Dekker, Inc., 1998: 383.
2. Colvin RB. The renal allograft biopsy. Kidney Int 1996; 50: 1069.
3. Nadasdy T, Krenacs T, Kalmar KN, Csajbok E, Boda K, Ormos J. Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study. Pathol Res Pract 1991; 187: 178.
4. Racusen LR, Solez K, Colvin RB, et al. The Banff '97 Working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
5. Gaber LW, Moore LW, Alloway RR, et al. Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 1996; 49: 481.
6. Teramoto N, Barker AB, Tonoyama Y, et al. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies. Cancer 1996; 77: 2339.
7. David-Neto E, Ribiero LE, lanhez S, Palomino LB, Saldanha SA, Sabbaga E. Acute interstitial nephritis of plasma cells: a new cause for renal allograft loss. Transplant Proc 1993; 25: 897.
8. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles DM, ed. Neoplastic hematopathology. Baltimore, MD: Williams & Wilkins, 1992: 459.
9. Nalesnick MA, Jaffe R, Starzl TE, et al. The Pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133: 173.
10. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL. Lymphoproliferative disorders and hematologic malignancies following organ transplantaion. Modern Pathol 1989; 2: 583.
11. Trpkov K, Marcussen N, Rayner D, Lam G, Solez K. Kidney allograft with a lymphocytic infiltrate: acute rejection, posttransplantation lymphoproliferative disorder, neither, or both entities? Am J Kidney Dis 1997; 30: 449.
12. Randhawa PS, Magnone M, Jordan M, Shapiro R, Demetris AJ, Nalesnik M. Renal allograft involvement by Epstein-Barr virus associated post-transplant lymphoproliferative disease. Am J Surg Pathol 1996; 20: 563.
13. Salomon DR. A molecular basis for transplantation immunity. In: Racusen LC, Solez K, Burdick JF eds. Kidney Transplant Rejection - Diagnosis and Treatment, 3rd Ed. New York: Marcel Dekker, Inc. 1998: 1.
14. Slakey DP, Thomas JM. Mechanisms of cell-mediated rejection. In: Racusen LC, Solez K, Burdick JF eds. Kidney transplant rejection, diagnosis and treatment, 3rd Ed. New York: Marcel Dekker, Inc., 1998: 33.
15. Picotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop DK. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997; 63: 619.
16. Detrick B, Hooks JJ. Cytokines in transplantation. AMLI Interact 1998; 3: 4.
17. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993; 55: 1159.
18. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T-cell receptor gene expression at the site of allograft rejection. Transplantation 1992; 53: 151.
19. VanBuskirk AM, Wakely ME, Orosz C. Transfusion of polarized Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996; 62: 229.
20. Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK. In vivo depletion of CDS+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155.
21. Paul LC. The molecular basis of chronic rejection. In: racusen LC, Solez K, Burdick JF, eds. Kidney Transplant Rejection-Diagnosis and Treatment, 3rd Ed. New York: Marcell Dekker, Inc., 1998: 177.